Purchase Order 36C24725P0221

Award Date 12/4/24
Potential Completion Date 3/31/25
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, NH 03801, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Novocure Inc.'s Optune Plus transducers to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). Novocure, a foreign-owned, for-profit manufacturer of medical devices, is the prime contractor on this $49,748.73 firm-fixed-price delivery order contract (Award ID: 36F79723D0016|36C25524K0526) with a period of performance through December 31, 2024. The contract was awarded by the VA VHA's Veterans Integrated Service...
This federal contract award is for the delivery of Novocure Inc.'s Optune Plus transducers to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). Novocure, a foreign-owned manufacturer of medical devices, is the prime contractor on this $49,748.73 firm fixed-price delivery order contract (Contract ID: 36F79723D0016|36C25525K0150) with a period of performance through March 31, 2025. The award is issued under Novocure's existing 5-year Federal Supply Schedule (FSS)...
This federal contract award is for the delivery of Novocure Inc.'s Optune Plus transducers to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, was awarded on September 26, 2023, with a completion date of December 25, 2023. Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is the prime contractor on this delivery order contract. The contract does not utilize any set-aside designations. Novocure's...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 firm fixed-price delivery order is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services. The contract has a period of performance through June 26, 2024. Novocure's Optune system delivers alternating electric fields to disrupt solid...
This federal contract award is for the delivery of Novocure Inc.'s Optune Plus transducers to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is a Firm Fixed Price Delivery Order issued under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85 million. Novocure, a foreign-owned, for-profit manufacturer of medical devices, is the prime contractor on this award. The...
This federal contract award is for the provision of Novocure Inc.'s Optune Plus Transducer Therapy System to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). Novocure, a foreign-owned, for-profit manufacturer of medical devices, is the prime contractor on this $49,748.73 firm-fixed-price delivery order contract. The contract, which does not utilize any set-aside designations, was awarded on March 27, 2024, with a period of performance through June 26, 2024....
This federal contract award is for the delivery of Novocure Inc.'s Optune Plus transducers to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract has a fixed-price delivery order value of $49,748.73 and a completion date of March 7, 2024. Novocure, a foreign-owned, for-profit manufacturer of medical devices, is the prime contractor on this award, which does not utilize any set-aside designations. The contract is issued under Novocure's existing...
This federal contract award is for the provision of Novocure Inc.'s Optune Plus transducers, device rentals, and related support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, which does not utilize any set-aside designations, was awarded on December 8, 2022, with a ceiling value of $63,000.00 and a period of performance through December 8, 2023. Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is the...
This federal contract award is for the delivery of Novocure Inc.'s Optune Plus transducers to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $99,497.46, is a firm fixed-price delivery order issued under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a total ceiling value of $28.85 million. Novocure, a foreign-owned, for-profit manufacturer of medical devices, is the prime contractor on this award,...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, provides the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with Novocure's Optune Plus transducers, device rentals, and related support services. The $16,582.91 firm fixed-price delivery order was issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which was awarded in November 2022 and runs through October...

This federal contract award is for the delivery of Novocure Inc.'s Optune Plus transducers to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 firm-fixed-price purchase order was issued by the VA's VISN 7 network and has a performance period through March 31, 2025. Novocure, a foreign-owned, for-profit manufacturer of medical devices, is the prime contractor on this award. The contract does not utilize any set-aside designations.

Novocure's Optune system delivers alternating electric fields to disrupt solid tumor cancer cell division and is FDA-approved for the treatment of glioblastoma and mesothelioma. This award is part of a larger $28.85 million Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) the VA VHA awarded to Novocure in November 2022, which provides a streamlined procurement vehicle for VA facilities nationwide to obtain Novocure's innovative cancer treatment technologies and support services. The FSS contract runs through October 31, 2027, enabling the VA to expand veterans' access to this non-invasive cancer therapy option.

Generated 12/5/24, 9:57 AM